Skip navigation

Novo Nordisk A/S

Pharmaceuticals
Denmark
Revenue (US$ Millions)$2,830
Revenue Growth (%)0.08%
Net Income (US$ Millions)$326
Earnings Per Share (US$)$4.56
Total Equity (US$ Millions)$2,507
Profit Margin (%)11.52%
Debt To Equity Ratio (%)0.20%